These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [alpha 1-antitrypsin deficiency and liver diseases]. von Schönfeld J; Breuer N Dtsch Med Wochenschr; 1993 Dec; 118(49):1819-24. PubMed ID: 8253047 [No Abstract] [Full Text] [Related]
26. Transgenic mouse models and hepatocellular carcinoma: future prospects. Lakhtakia R; Panda SK Trop Gastroenterol; 2000; 21(3):91-4. PubMed ID: 11084827 [No Abstract] [Full Text] [Related]
27. [Hepatitis B virus and hepatocellular carcinoma: the track of chromosome X]. Ratziu V Gastroenterol Clin Biol; 1993; 17(4):314-6. PubMed ID: 8393413 [No Abstract] [Full Text] [Related]
28. TGF-beta and hepatocellular carcinoma. Bortolami M; Cardin R; Kotsafti A; Farinati F Hepatology; 2008 Mar; 47(3):1095; author reply 1095-6. PubMed ID: 18306219 [No Abstract] [Full Text] [Related]
29. Hepatocellular carcinoma--carcinogenesis updated. Yap I Singapore Med J; 1995 Dec; 36(6):597-9. PubMed ID: 8781628 [No Abstract] [Full Text] [Related]
30. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253 [TBL] [Abstract][Full Text] [Related]
31. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Fargion S; Bissoli F; Fracanzani AL; Suigo E; Sergi C; Taioli E; Ceriani R; Dimasi V; Piperno A; Sampietro M; Fiorelli G Hepatology; 1996 Nov; 24(5):1161-4. PubMed ID: 8903392 [TBL] [Abstract][Full Text] [Related]
32. [Hepatocellular carcinoma in the non-cirrhotic liver: renewed interest]. Bernard PH; Blanc JF; Le Bail B; de Ledinghen V; Rullier A; Balabaud C; Bioulac-Sage P Gastroenterol Clin Biol; 1998 Apr; 22(4):371-4. PubMed ID: 9762265 [No Abstract] [Full Text] [Related]
33. [Cancer of the liver in rats with alimentary cirrhosis]. Volgarev MN Arkh Patol; 1970; 33(2):38-43. PubMed ID: 4333352 [No Abstract] [Full Text] [Related]
34. Alpha-1-antitrypsin deficiency resulting in a hitherto unseen presentation of hepatocellular carcinoma: polycythemia but with normal alpha fetoprotein. Owen DR; Sivakumar R; Suh ES; Seevaratnam M World J Gastroenterol; 2006 Aug; 12(30):4906-7. PubMed ID: 16937479 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Bannasch P Prog Liver Dis; 1996; 14():161-97. PubMed ID: 9055578 [No Abstract] [Full Text] [Related]
36. Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat. Farber E Monogr Pathol; 1987; (28):199-222. PubMed ID: 3023976 [No Abstract] [Full Text] [Related]
37. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
39. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice. Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774 [TBL] [Abstract][Full Text] [Related]